Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-19-007999
Filing Date
2019-12-06
Accepted
2019-12-06 16:20:43
Documents
3
Period of Report
2019-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_120519.htm 6-K 9256
2 EXHIBIT 99.1 exh_991.htm EX-99.1 8045
3 EXHIBIT 99.2 exh_992.htm EX-99.2 19023
  Complete submission text file 0001171843-19-007999.txt   37448
Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39084 | Film No.: 191273384
SIC: 2836 Biological Products, (No Diagnostic Substances)